February 01, 2007
FDA proposed rules revisions
The FDA has proposed rules revisions intended to expand the availability of experimental drugs, to decrease confusion over charging practices for those drugs and improve the safety of them.
Congress has finally passed the Right to Try Act, but does it go far enough?
The government agency released its latest guidance this week.
11 questions for the GW CEO on the watershed moment.